Long-term outcome of interferon-α-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 1925-1929

  Carella, Carlo ^a   Mazziotti, Gherardo ^a   Morisco, Filomena ^a   Manganella, Giovanni ^a   Rotondi, Mario ^a   Tuccillo, Concetta ^a   Sorvillo, Francesca ^a   Caporaso, Nicola ^a   Amato, Giovanni ^a  

^a Department of Food Science ^*

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; RECOMBINANT ALPHA2A INTERFERON; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; CORRELATION FUNCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HASHIMOTO DISEASE; HEPATITIS C; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNITY; FEMALE; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PROGNOSIS; THYROID GLAND;

HEPATITIS C VIRUS;

EID: 0034996611     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.5.1925     Document Type: Article

References (25)

1. Shiratori Y, Yokosuka O, Nakata R, et al. 1999 Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA. Hepatology. 29:1573-1580.
2. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. 1992 Development of thyroid disease during therapy of chronic viral hepatitis with interferon α. Gastroenterology, 102:2155-2160.
3. Carella C, Amato G, Biondi B, et al. 1995 Longitudinal study of antibodies against thyroid in patients undergoing interferon α therapy for HCV chronic hepatitis. Horm Res. 44:110-114.
4. Imagawa A, Itoh N, Hanafusa T, et al. 1995 Autoimmune endocrine disease induced by recombinant interferon α therapy for chronic active type C hepatitis. J Clin Endocrinol Metab. 80:922-926.
5. Marazuela M, Garcia-Buey L, Fernadez-Gonzalez B, et al. 1996 Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy. Clin Endocrinol (Oxf). 44:635-642.
6. Koh LKH, Greenspan FS, Yeo PPB. 1997 Interferon α induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid. 7:891-896.
7. Deutsch M, Dourakis S, Manesis EK, et al. 1997 Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon α therapy. Hepatology. 26:206-210.
8. Fernadez-Soto L, Gonzalez A, Escobar-Jimenez F, et al. 1998 Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during and after discontinuing interferon therapy. Arch Intern Med. 158:1445-1448.
9. Baudin E, Marcellin P, Pouteau M, et al. 1993 Reversibility of thyroid dysfunction induced by recombinant a interferon in chronic hepatitis C. Clin Endocrinol (Oxf). 39:657-661.
10. Vanderpump MPJ, Tunbridge WMG, French JM, et al. 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf). 43:55-68.
11. Kakizaki S, Takagi H, Murakami M, Takayama H, Mori M. 1999 HLA-antigens in patients with interferon-α-induced autoimmune thyroid disorders in chronic hepatitis C. J Hepatol. 30:794-800.
12. Weetman AP, McGregor AM. 1994 Autoimmune thyroid disease: further developments in our understanding. Endocr Rev. 15:788-830.
13. Remy J, Salamero J, Michel-Bechet M, et al. 1987 Experimental autoimmune thyroiditis induced by recombinant interferon-γ. Immunol Today. 8:73.
14. Shuppert F, Rambusch E, Kirchner H, Atzpodien J, Kohn LD, von zur Muhlen A. 1997 Patients treated with Interferon α, interferon β and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid disease. Thyroid. 7:837-842.
15. Yoshida H, Amino N, Yagawa K, et al. 1978 Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab. 46:859-862.
16. Kasagy K, Kousaka T, Higuchi K, et al. 1996 Clinical significance of measurements of antithyroid antibodies in the diagnosis of Hashimoto's thyroiditis: comparison with histological findings. Thyroid. 6:445-450.
17. Barbesino G, Chiovato L, 2000 The genetics of Hashimoto's disease. Endocrinol Metab Clin North Am. 29:357-374.
18. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. 1994 The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. Am J Gastroenterol. 89:399-403.
19. Marcellin P, Pouteau M, Baudin E, et al. 1991 Thyroid dysfunction induced by recombinat interferon in patients with chronic hepatitis C: a prospective study. Hepatology. 14:77-A.
20. Tsuboi K, Katayama M, Yuasa R, et al. 1998 Interferon-alpha-induced thyroid dysfunction in patients with chronic active hepatitis C: a transient, reversible and self-limited dysfunction. Intern Med. 37:27-31.
21. Sato K, Miyakawa M, Demura H. 1996 Reversible, extremely severe hypothyroidism in a patient with chronic hepatitis C treated with interferon-α. Thyroid. 6:249-252.
22. Yamazaki K, Kanaji Y, Shizume K, et al. 1993 Reversible inhibition by interferon alpha and beta of 1251 incorporation and thyroid hormone release by human thyroid follicles in vitro. J Clin Endocrinol Metab. 77:1439-.
23. Roti E, Minelli R, Giuberti T, et al. 1996 Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-α. Am J Med. 101:482-487.
24. Takamatsu J, Yoshida S, Yokozawa T, et al. 1998 Correlation of antithyroglobulin and antithyroid-peroxidase antibody profile with clinical and ultrasound characteristics of chronic thyroiditis. Thyroid. 8:1101-1106.
25. Cargnel A, Gubertini G, Magnani C, Bosis S, Colombo F, Clerici M. 1999 Immune response in chronic hepatitis C-infected patients undergoing interferon treatment. Hepatology. 30:584-585.